Review of scientific literature highlights 450 studies assessing the therapeutic efficacy of cannabis and cannabinoids

The report covers 23 different patient groups, including autism, chronic pain, diabetes and post-traumatic stress disorder.

The National Organization for the Reform of Marijuana Laws (NORML) has updated its Clinical Applications For Cannabis & Cannabinoids report and the publication now highlights 450 peer-reviewed studies assessing the safety and efficacy of whole-plant cannabis and individual cannabinoids.

The update arrives four years since the last report and contains nearly 100 new studies, according to a blog post from NORML.

Leave a Reply

Your email address will not be published.